GSK receives FDA approval for oral antibiotic to treat UTIs

The U.S. Food and Drug Administration has approved GSK's (NYSE: GSK) oral antibiotic for the treatment of complicated urinary tract infections, according to a statement from the regulator.

You May Also Be Interested In

• FDA set to permanently fill top drug, vaccine, and tobacco roles - Bloomberg
• U.S. Bancorp (USB) Raises Quarterly Dividend 3.8% to $0.54; 3.5% Yield
• Argo Graphene raises private placement target to $1.5M